NIPH Clinical Trials Search

UMIN ID: C000000256

Registered date:30/09/2005

Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedRenal cell carcinoma
Date of first enrollment2001/08/01
Target sample size540
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Administration of natural type interferon alpha for at least one year Observation


Primary OutcomeLocal recurrence and distant metastasis
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteriaActive synchronous malignancy Bellini duct carcinoma von Hippel-Lindau disease History of allergy for interferon or vaccine

Related Information


public contact
Name Hideyuki Akaza MD
Address Japan
Telephone 029-853-3223
Affiliation University of Tsukuba Department of Urology
scientific contact
Name Seiji Nito MD
Address Fukuoka Japan
Affiliation Kyushu University Department of Urology